COMMUNIQUÉS West-GlobeNewswire

Greenwich LifeSciences Extends Lock-up of Directors and Officers to March 31, 2026
27/03/2025
STAFFORD, Texas, March 27, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is [...]
Arialief Nerve Health Supplement Review: Benefits, Side Effects & Where to Buy
27/03/2025
AURORA, Colo., March 27, 2025 (GLOBE NEWSWIRE) -- Nerve health has become a critical concern for many individuals suffering from conditions such as neuropathy, sciatica, and other forms of chronic nerve discomfort. [...]
Zelluna ASA [ZLNA]: Share capital increase registered
27/03/2025
Oslo, Norway, 27 March, 2025 Reference is made to the stock exchange notice published on 26 March 2025 regarding the resolution of the board of directors of Zelluna ASA (the " Company ") to carry out a share capital [...]
LE QUÉBEC RATE UNE OCCASION DE GÉNÉRER DES REVENUS POUR LA SANTÉ PUBLIQUE
27/03/2025
MONTRÉAL, 27 mars 2025 (GLOBE NEWSWIRE) -- Avec déception, le Collectif Vital a constaté que le financement de la santé publique accuse un recul dans le budget 2025-2026 du ministre des Finances. La taxation des [...]
Alvotech Appoints Dr. Balaji V. Prasad as Chief Strategy Officer
27/03/2025
Alvotech (NASDAQ: ALVO, or the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the appointment of Dr. Balaji V. Prasad [...]
Alvotech Appoints Dr. Balaji V. Prasad as Chief Strategy Officer
27/03/2025
REYKJAVIK, Iceland, March 27, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO, or the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, [...]
Pleco Therapeutics annonce un résultat positif de sa réunion de pré-IND avec la FDA pour la poursuite du développement du PTX-252 dans le cadre du traitement de la leucémie myéloïde aiguë
27/03/2025
NIMÈGE, Pays-Bas, 27 mars 2025 (GLOBE NEWSWIRE) -- Pleco Therapeutics, société biopharmaceutique de phase clinique qui développe des thérapies innovantes pour les cancers difficiles à traiter, annonce un résultat [...]
CROSSJECT reports financial results for 2024
27/03/2025
Press Release CROSSJECT reports financial results for 2024 Continued satisfactory production of regulatory batches with a view to filing in Q2 2025. Recruitment of Tony Tipton as Chief Operating Officer USA. Visibility [...]
CROSSJECT publie ses résultats financiers pour 2024
27/03/2025
Communiqué de presse CROSSJECT publie ses résultats financiers pour 2024 Continuité dans la production satisfaisante de lots règlementaires en vue d’un dépôt de dossier en T2 2025. Recrutement de Tony Tipton aux Etats- [...]
Press release: Sequana Medical to Attend the “VFB Happening 2025” in Ghent, Belgium on Saturday, 29 March 2025
27/03/2025
Sequana Medical to Attend the “VFB Happening 2025” in Ghent, Belgium on Saturday, 29 March 2025 Ghent, Belgium – 27 March 2025 – Sequana Medical NV (Euronext Brussels: SEQUA, the "Company" or "Sequana Medical") , a [...]
Santhera proposes Dr. Melanie Rolli as new member of Board of Directors
27/03/2025
Ad hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland, March 27, 2025 – Santhera Pharmaceuticals (SIX: SANN) proposes to elect Dr. Melanie Rolli as an Independent Director at the upcoming Annual General [...]
Idorsia publishes its Annual Report 2024
27/03/2025
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – March 27, 2025 Idorsia Ltd (SIX: IDIA) today announced the publication of the Annual Report 2024 – consisting of the Business Report, Governance Report [...]
Amaran Biotech Wins "Best CDMO in Automated Aseptic Filling"
27/03/2025
Honored at Taiwan Biopharma Excellence Awards 2025 TAIPEI, Taiwan, March 27, 2025 (GLOBE NEWSWIRE) -- Amaran Biotech, a next-generation Contract Development and Manufacturing Organization (CDMO), was honored with the " [...]
Junshi Biosciences Announces Toripalimab’s Approval in Singapore
27/03/2025
SHANGHAI, March 26, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, [...]
Scilex Holding Company Has Appealed Lower Court Decision to the U.S. Court of Appeals for the Federal Circuit in Washington, DC and Will Continue to Vigorously Pursue its Infringement Action Against Aveva
27/03/2025
PALO ALTO, Calif., March 26, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non- [...]
Ryoncil® is Now Available for Purchase in the United States
27/03/2025
NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that Ryoncil ® (remestemcel-L) the first [...]
23andMe Confirms All Potential Buyers Must Agree to Comply With Privacy Policy and Applicable Law
26/03/2025
Receives Court Approval for First Day Motions to Support Ongoing Business Operations SAN FRANCISCO, March 26, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (“23andMe” or the “Company”) (Nasdaq: ME), a leading human [...]
Alvotech Reports Record Results for 2024 and Provides Business Update
26/03/2025
Total Revenues in 2024 reached $492 million, representing a 427% increase over prior year Product Revenues in 2024 reached $273 million, representing a 462% increase over prior year Adjusted EBITDA in 2024 was $108.3 [...]
Alvotech Reports Record Results for 2024 and Provides Business Update
26/03/2025
Total Revenues in 2024 reached $492 million, representing a 427% increase over prior year Product Revenues in 2024 reached $273 million, representing a 462% increase over prior year Adjusted EBITDA in 2024 was $108.3 [...]

Pages